Maternal blood test reveals prenatal methylation clues linked to autism risk

Stiinta si Tehnologie

By Dr. Priyom Bose, Ph.D. Reviewed by Lauren Hardaker Jun 25 2026 Maternal blood cell-free DNA methylation may offer a minimally invasive research window into prenatal epigenetic signatures associated with later autism diagnosis, supporting future biomarker and early intervention studies. WGBS of cfDNA in a prospective autism cohort study enables prenatal detection of ASD-associated differentially methylated regions (DMRs). This experimental diagram details the process by which study

Tag-uri: DNA